TotalMarketCap

Adagene

ADAGNasdaq ChinaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$133.424 M

$2.02 -16.18%

Close of 6 Nov 2026

As of 6 Nov 2026, Adagene (ADAG) has a market capitalization of $133.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$7.67M

#3186 by revenue

Earnings

-$17.6M

Loss-making

Shares outstanding

59,231,993

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #269Veraxa Biotech AG - Post de-SPACVRXA$139.4M
  2. #270Satellos BioscienceMSLE$135.8M
  3. #271AdageneADAG$133.4M
  4. #272Organigram GlobalOGI$132.3M
  5. #273Jyong BiotechMENS$129.2M

What if Adagene were worth as much as…

Open the what-if tool →

Gold $28.2T

$427,497.24

Per share 211,632× higher

Bitcoin $1.53T

$23,131.13

Per share 11,451× higher

Apple $5.02T

$75,937.34

Per share 37,593× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Adagene are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.